Related Experiment Video
Updated: Jun 18, 2026
05:22
Isolation and Propagation of Circulating Tumor Cells from a Mouse Cancer Model
Published on: October 9, 2015
Circulating tumor cells in gastrointestinal malignancies: current techniques and clinical implications
Georg Lurje1, Marc Schiesser, Andreas Claudius
1Department of Visceral- and Transplantation Surgery, Department of Surgery, University Hospital Zurich, 8091 Zurich, Switzerland.
Journal of Oncology
|November 11, 2009
Summary
Circulating tumor cells (CTCs) are valuable for detecting cancer and monitoring treatment response in gastrointestinal cancers. However, relying on a single CTC marker may not accurately predict disease progression due to multiple contributing factors.
Area of Science:
- Oncology
- Molecular Diagnostics
- Cancer Biomarkers
Background:
- Circulating tumor cells (CTCs) have been studied for over 50 years.
- CTC detection correlates with clinical outcomes in esophageal, gastric, and colorectal cancers.
- Refined technologies enhance CTC identification for malignancy detection and treatment monitoring.
Purpose of the Study:
- To discuss the current concept of CTCs.
- To summarize available techniques for CTC detection and characterization.
- To provide a comprehensive update on the clinical implications of CTCs in gastrointestinal (GI) malignancies.
Main Methods:
- Review of current literature on CTCs.
- Analysis of detection and characterization technologies.
- Synthesis of clinical implications in GI cancers.
Main Results:
- CTC detection is a promising tool for malignancy detection, disease monitoring, and therapy response assessment.
- Analysis of a single CTC marker is insufficient for accurate and reproducible disease progression prediction.
- Multiple factors influence disease progression, necessitating a comprehensive approach.
Conclusions:
- CTCs hold significant potential in managing GI malignancies.
- Advanced CTC detection technologies are crucial for accurate prognostication.
- A multi-marker or integrated approach is likely required for reliable prediction of disease progression.
